UK Companies House feature
CATALENT UK SUPPLY CHAIN LIMITED
Cash
—
Latest balance sheet
Net assets
£2M
-9.4% vs 2020
Employees
0
Average over period
Profit before tax
-£166K
+47.8% vs 2020
Profile
- Company number
- 02425939
- Status
- Active
- Incorporation
- 1989-09-25
- Last accounts made up
- 2024-06-30
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Net assets
2-year trend · vs UK Healthcare median
Accounts
2-year trend · latest 2021-06-30
| Metric | Trend | 2020-06-30 | 2021-06-30 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£88,160 | £62,775 | |
| Profit before tax | -£317,190 | -£165,629 | |
| Net profit | — | — | |
| Cash | — | — | |
| Total assets less current liabilities | £15,188,393 | £15,251,168 | |
| Net assets | £1,756,459 | £1,590,830 | |
| Equity | £1,756,459 | £1,590,830 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have assessed that the company would be profitable and cash generating throughout the going concern period to 30 June 2026. The Company forecasts, taking account of reasonably possible changes in trading performance...the directors have formed a reasonable expectation...continue to operate for the foreseeable future.”
Subsidiaries
- Catalent Nottingham Limited · 100% held · England · Contract research, development, and consultancy services, primarily to the pharmaceutical industry.
Significant events
- “On 18th December 2024, the ultimate parent, Catalent Inc. completed the merger agreement with Novo Holdings... Catalent shareholders voted to approve the transaction with 99.2% of ballots cast in favour...”
- “Subsequent to year end 30 June 2024, Novo Nordisk Holding A/S (Denmark), a company incorporated in Denmark, acquired 100% of issued share capital of Catalent Inc.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 26 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BARNETT, Kate Toller | Director | 2025-04-01 | Jun 1974 | British |
| CERON, Ramon Javier, Mr. | Director | 2025-04-01 | Aug 1969 | American |
| GENNADIOS, Aristippos | Director | 2025-04-01 | May 1965 | American |
Show 26 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CHAMBERS, Michael | Secretary | 1995-11-06 | 2013-12-31 |
| WALSH, Kirk | Secretary | 2018-09-27 | 2022-12-01 |
| GRAY'S INN SECRETARIES LIMITED | Corporate Nominee Secretary | — | 1995-11-06 |
| ARNOLD, Jonathan | Director | 2018-09-27 | 2022-09-14 |
| BLONDEAU, Annick | Director | 1996-06-10 | 2001-06-30 |
| BOLOGNA, William Joseph | Director | — | 2003-04-15 |
| CARLETTI, Lorenzo | Director | 2022-05-31 | 2025-04-01 |
| CARTIER, Philippe Jean | Director | 1998-10-15 | 2001-03-30 |
| CARVAIS, Jean Emmanuel Norbert | Director | 1998-10-15 | 2004-05-26 |
| CHAMBERS, Michael | Director | — | 2013-12-31 |
| CONDELLA, Frank C | Director | 2010-05-14 | 2016-07-31 |
| DICK, Colin Allister James, Mr. | Director | 2022-12-01 | 2025-04-01 |
| ELSTON, George | Director | 2014-10-01 | 2016-12-31 |
| HAWKESWOOD, Thomas | Director | 2022-09-14 | 2025-04-01 |
| HOPSON, Ricky | Director | 2022-09-14 | 2022-09-15 |
| LLOYD JONES, Jonathan Brian | Director | 2013-01-21 | 2014-10-31 |
| MASELLI, Alessandro | Director | 2018-09-27 | 2022-05-31 |
| MCGRANE, Michael | Director | 2004-06-10 | 2013-01-15 |
| MEIR, James Norman Max | Director | — | 2001-03-30 |
| MILLS JR, Robert Stephen, Senior V P And Coo | Director | 2004-06-10 | 2010-05-14 |
| NEEDHAM, David Alan, Dr | Director | — | 1993-05-21 |
| PATEL, Nikin, Dr | Director | 2014-04-14 | 2019-03-29 |
| PERCIVAL, Philip Charles | Director | — | 1992-12-31 |
| SECOR, Alicia | Director | 2016-08-01 | 2018-09-27 |
| WALSH, Kirk | Director | 2018-09-27 | 2022-12-01 |
| YOUNG, Jeffrey | Director | 2017-01-01 | 2018-09-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Catalent, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-08-13 | Active |
| Juniper Pharmaceuticals, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2018-08-13 |
Filing timeline
Last 20 of 196 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-11-14 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-07-08 | AA | accounts | accounts with accounts type full |
| 2025-04-17 | AP01 | officers | appoint person director company with name date |
| 2025-04-17 | AP01 | officers | appoint person director company with name date |
| 2025-04-17 | AP01 | officers | appoint person director company with name date |
| 2025-04-17 | TM01 | officers | termination director company with name termination date |
| 2025-04-17 | TM01 | officers | termination director company with name termination date |
| 2025-04-17 | TM01 | officers | termination director company with name termination date |
| 2025-01-13 | AA01 | accounts | change account reference date company current extended |
| 2024-11-25 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-08-07 | AA | accounts | accounts with accounts type full |
| 2024-01-18 | AA | accounts | accounts with accounts type small |
| 2024-01-17 | AAMD | accounts | accounts amended with accounts type full |
| 2023-12-15 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-01-20 | AP01 | officers | appoint person director company with name date |
| 2023-01-20 | TM01 | officers | termination director company with name termination date |
| 2023-01-20 | TM02 | officers | termination secretary company with name termination date |
| 2022-12-02 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-11-11 | TM01 | officers | termination director company with name termination date |
| 2022-10-10 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory